Drug Profile
DY 9760
Alternative Names: DY 9760eLatest Information Update: 13 May 2008
Price :
$50
*
At a glance
- Originator Daiichi Sankyo Company
- Class Piperazines
- Mechanism of Action Calmodulin antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders